These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3875758)

  • 1. The release of endogenous dopamine from rat striatum during incubation in vitro.
    Snape BM; Holman RB
    J Neurosci Methods; 1985 Jun; 14(1):53-64. PubMed ID: 3875758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
    Hársing LG; Vizi ES
    Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCl-induced calcium-independent release of endogenous dopamine from rat brain slices.
    Okuma Y; Osumi Y
    Brain Res; 1986 Jan; 363(1):47-52. PubMed ID: 3947956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of reuptake inhibitors on dopamine release from the stalk-median eminence and posterior pituitary in vitro.
    Garris PA; Ben-Jonathan N
    Brain Res; 1991 Aug; 556(1):123-9. PubMed ID: 1933344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mazindol, nomifensine and desmethylimipramine inhibit potassium-induced release of dopamine: effect of stimulus strength.
    Dembiec-Cohen D
    J Neural Transm (Vienna); 1998; 105(6-7):735-47. PubMed ID: 9826115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol enhances the calcium-dependent stimulus-induced release of endogenous dopamine from slices of rat striatum and nucleus accumbens in vitro.
    Snape BM; Engel JA
    Neuropharmacology; 1988 Nov; 27(11):1097-101. PubMed ID: 3205382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous dopamine release from rat striatal slices and its regulation by D-2 autoreceptors: effects of uptake inhibitors and synthesis inhibition.
    Herdon H; Strupish J; Nahorski SR
    Eur J Pharmacol; 1987 Jun; 138(1):69-76. PubMed ID: 3622608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dopamine uptake and release in vitro in sheep and rat striatum.
    Jacocks HM; Izenwasser S; Werling LL; Cox BM
    Life Sci; 1991; 49(7):481-8. PubMed ID: 1830633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outflow and overflow of picogram levels of endogenous dopamine and DOPAC from rat striatal slices: improved methodology for studies of stimulus-evoked release and metabolism.
    Gerhardt GA; Dwoskin LP; Zahniser NR
    J Neurosci Methods; 1989 Jan; 26(3):217-27. PubMed ID: 2521916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin potentiates the potassium-induced release of endogenous dopamine from rat striatal slices.
    Okuma Y; Fukuda Y; Osumi Y
    Eur J Pharmacol; 1983 Sep; 93(1-2):27-33. PubMed ID: 6628546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
    Cass WA; Larson G; Fitzpatrick FA; Zahniser NR
    J Pharmacol Exp Ther; 1991 Jun; 257(3):990-6. PubMed ID: 1828506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of two primary human metabolites of nomifensine on stimulated efflux and uptake of dopamine in the striatum: in vitro voltammetric data in slices of rat brain.
    Hafizi S; Palij P; Stamford JA
    Neuropharmacology; 1992 Aug; 31(8):817-24. PubMed ID: 1356256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
    Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
    Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices.
    Snape BM; Pileblad E; Ekman A; Magnusson T; Carlsson A; Engel J
    J Pharm Pharmacol; 1988 Sep; 40(9):620-6. PubMed ID: 2907028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices.
    Flint RS; Murphy JM; McBride WJ
    Neurochem Res; 1985 Apr; 10(4):515-27. PubMed ID: 2860579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.